Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes.
Núñez-Carpintero I, Rigau M, Bosio M, O'Connor E, Spendiff S, Azuma Y, Topf A, Thompson R, 't Hoen PAC, Chamova T, Tournev I, Guergueltcheva V, Laurie S, Beltran S, Capella-Gutiérrez S, Cirillo D, Lochmüller H, Valencia A.
Núñez-Carpintero I, et al.
Nat Commun. 2024 Feb 28;15(1):1227. doi: 10.1038/s41467-024-45099-0.
Nat Commun. 2024.
PMID: 38418480
Free PMC article.